The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index; 8 of the 300 sources its claims cite were checked for support.
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Open accessAbstract
Metabolic reprogramming has become a key focus for both immunologists and cancer biologists, with exciting advances providing new insights into the mechanisms underlying disease. There is now extensive evidence that intermediates and derivatives of the mitochondrial Krebs cycle—metabolites traditionally associated with bioenergetics or biosynthesis—also possess ‘non-metabolic’ signalling functions. In this review, we summarize the non-metabolic signalling mechanisms of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers (d-2-hydroxyglutarate and l-2-hydroxyglutarate) and acetyl-CoA, with a specific focus on how such signalling pathways alter immune cell and transformed cell function. We believe that the insights gained from immune and cancer cells that are summarized here will also be useful for understanding and treating a range of other diseases. Intermediate metabolites of the Krebs cycle serve bioenergetic and biosynthetic needs but have recently also been linked to signalling. The authors of this Review summarize such non-metabolic signalling functions of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers and acetyl-CoA in both immune cells and cancer cells.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that Krebs cycle intermediates—succinate, itaconate, fumarate, 2-HG, and acetyl-CoA—act as signalling molecules in immune cells and cancer beyond bioenergetics. It synthesizes mechanisms by which these metabolites alter inflammation, epigenetics, and tumorigenesis, and discusses therapeutic implications.
Key findings
- Succinate accumulates in LPS/IFN-γ-treated macrophages and promotes inflammation via SUCNR1, HIF-1α stabilization, mtROS/RET at complex I, succinylation, and epigenetic regulation; SDH inhibition by DMM/malonate reduces LPS-induced HIF-1α, IL-1β, and ROS and boosts IL-10/IL-1RA.
- Itaconate, produced by IRG1/CAD from cis-aconitate, is anti-inflammatory: it inhibits SDH, induces Nrf2 via KEAP1 cysteine alkylation (e.g., C151), and can regulate the IκBζ–ATF3 axis; 4-OI was protective in LPS lethality. In peritoneal tumours, tumour-infiltrating macrophage-derived itaconate boosted OXPHOS/mtROS/MAPK and tumour growth.
- Fumarate acts as an oncometabolite and immunomodulator: FH mutations cause HLRCC; fumarate succinates KEAP1, GAPDH, ACO2, and Fe-S proteins, inhibits α-KGDDs/TETs/JMJDs, drives pseudohypoxia and EMT; in β-glucan-trained monocytes fumarate accumulation is required for trained immunity and H3K4me3 at Tnf/Il6.
- 2-HG enantiomers regulate immunity/cancer: D-2-HG from mutant IDH1/2 inhibits α-KGDDs (KDM IC50 24–106 μM; FIH 1.5 mM; PHD2 7.3 mM) and accumulates up to 35 mM in IDH-mutant glioma; L-2-HG rises up to 1.5 mM in TCR-triggered mouse CD8+ T cells and enhances anti-tumour capacity. Acetyl-CoA from citrate via ACLY supports histone acetylation and immune/tumour gene expression.
Methods
- Narrative review; no primary experimental design, sample, or dataset is reported.
- Synthesizes published literature on succinate, itaconate, fumarate, 2-HG, and acetyl-CoA in immunity and cancer; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Main analysis is conceptual/mechanistic synthesis with figures and therapeutic discussion.
Limitations
- Stated: limited human and in vivo data; rapid steady-state metabolism makes accurate in vivo snapshots challenging; human immune cell studies are limited.
- Stated: many open questions remain about metabolite ratios/compartments, unidentified GPCRs/transporters, and whether metabolites are biomarkers or drivers; oncometabolite findings often come from rare cancer syndromes.
- Evident: as a narrative review, it does not systematically assess evidence quality or quantify bias; many mechanistic claims rely on mouse/cell-line studies and cited primary papers.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
219 Not checked yet · 21 Own interpretation · 6 No basis given · 2 Partly supported · 2 Couldn’t confirm · accuracy not yet measured
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As mentioned, fumarate also inhibits a variety of α-KGDDs, enzymes involved in multiple cellular processes, from metabolism to signalling and epigenetics90-92”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Could not verifycites [90] Blewett, M. M. et al. Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. Sci. Signal. 9, rs10 (2016). sourceExperimental — accuracy not yet measured
The Introduction discusses dimethyl fumarate’s proposed effects on cysteine-containing proteins, and the Results report inhibition of T-cell activation by dimethyl fumarate. Searches for α-KGDD, dioxygenase, and 2-oxoglutarate-dependent dioxygenases found no passage in our copy addressing whether fumarate inhibits those enzymes. (LLM, conf=0.74)
- Could not verifycites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). sourceExperimental — accuracy not yet measured
The paper’s discussion of protein succination (pp. 613–615) says fumarate can modify many proteins and describes inhibition of GAPDH. Searches for α-KGDDs and α-ketoglutarate-dependent dioxygenases found no passage addressing whether fumarate inhibits that enzyme class. (LLM, conf=0.78)
- Could not verifycites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). sourceExperimental — accuracy not yet measured
The supplied passages and searches for α-KGDDs and α-ketoglutarate-dependent dioxygenases found no discussion of that enzyme class. The paper instead discusses fumarate-mediated inactivation of GAPDH and inhibition of GAPDH by dimethyl fumarate (Abstract; page not provided). That does not establish whether fumarate inhibits α-KGDDs. (LLM, conf=0.72)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, it was shown that fumarate can drive succination of several members of the family of Iron Sulfur (Fe-S) cluster biogenesis proteins, causing a depletion of Fe-S clusters required for the activity of mitochondrial enzymes, including complex I88.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Partly supportedcites [88] Xiao, M. et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326–1338 (2012). sourceExperimental — accuracy not yet measured
The Discussion (page not available in our copy) says fumarate can cause aberrant succination of many proteins, including KEAP1. It does not identify Fe-S cluster biogenesis proteins as targets or report Fe-S cluster depletion or an effect on mitochondrial complex I activity. (LLM, conf=0.83)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“DMM could also decrease inflammation in a mouse model of sepsis28.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Could not verifycites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). sourceExperimental — accuracy not yet measured
The section on TRAP1, respiration, and cancer discusses succinate accumulation and tumor growth, not DMM or sepsis. Searches for DMM and dimethyl malonate in relation to inflammation in a mouse sepsis model found no passage addressing the claim in our copy. (LLM, conf=0.78)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
In the paper
“A selective antagonist for human and rat has been shown to be protective in hypertension, a disease in which succinate is elevated11.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [11] Hollander, A. P., Corke, K. P., Freemont, A. J. & Lewis, C. E. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540–1544 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“LPS can also stabilize HIF-1α indirectly, by increasing succinate levels.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It transcriptionally directs a switch in metabolism from oxidative phosphorylation to glycolysis, which allows rapid ATP production without the need for oxygen15.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [15] Lewis, G. D. et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2, 33ra37 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“HIF-1α is tightly regulated by prolyl hydroxylases (PHD), a class of α-ketoglutarate (α-KG)-dependent dioxygenases (α-KGDDs) that convert α-KG to succinate and use molecular oxygen to hydroxylate HIF-1α.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Priming of DCs with succinate and antigen simultaneously, elevates antigen-specific T cell activation, increasing TNFα and IFN-γproduction from these cells4.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“More recently, however, it has been demonstrated that succinate accumulation in tumours promotes angiogenesis via upregulation of vascular endothelial growth factor (VEGF) in a HIF-1α-independent manner.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [23] Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“SUCNR1 ligation on MoDC or the U937 macrophage cell line induces cell migration, suggesting that succinate can act as a chemokine4.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 98
- Probably not a substantial claim. 7
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“High levels of succinate or 2-HG inhibit α-KGDDs. These include the PHDs, the TET DNA demethylases, and the JMJDs154-156”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
- Not checked yetcites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
- Not checked yetcites [62] Sugimoto, M. S. H. Y. et al. Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 8, 624–633 (2011). source
- Partly supportedcites [154] Sasaki, M. et al. d-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes Dev. 26, 2038–2049 (2012). sourceExperimental — accuracy not yet measured
The passages labeled Abstract identify TET enzymes and Jumonji-domain histone demethylases as possible D2HG targets and state that succinate inhibits PHDs. The ROS section reports evidence consistent with D2HG inhibition of TET enzymes and says the authors concur that it blocks PHD-mediated modification, but it also notes conflicting PHD findings and no change in histone methylation in their cells. The copy does not establish that succinate inhibits TET enzymes or JMJDs, so the claim's unqualified grouping overstates the evidence. (LLM, conf=0.83)
- Partly supportedcites [155] Tarhonskaya, H. et al. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat. Commun. 5, 3423 (2014). sourceExperimental — accuracy not yet measured
The introduction (page unavailable) says elevated succinate and 2-HG are proposed to inhibit 2-oxoglutarate oxygenases. The paper reports 2-HG inhibition of a JmjC demethylase, but treats inhibition of TET enzymes as possible and finds that 2-HG is only a weak inhibitor of PHD2. The claim presents inhibition across all three enzyme groups more definitively than the source does. (LLM, conf=0.85)
- Partly supportedcites [156] Wang, P. et al. Oncometabolite d-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 13, 2353–2361 (2015). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says D-2-HG inhibits α-KG-dependent dioxygenases, including JmjC histone demethylases and TET DNA hydroxylases. Our copy does not support the additional claims that succinate inhibits these enzymes or that PHDs are among the inhibited enzymes; searches for succinate and PHDs/prolyl hydroxylases found no relevant passage. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“HIF-1 binds to hypoxia response elements (HREs) in target genes and increases the expression of numerous glycolytic enzymes and the glucose transporters (GLUT)1 and GLUT3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Analogous to tumours, LPS-induced succinate was shown to both directly and indirectly (via ROS) inhibit PHD activity in macrophages resulting in stabilization of HIF-1α2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“An additional mechanism by which succinate accumulates tumors involves the mitochondrial chaperone, tumor necrosis factor receptor-associated protein 1 (TRAP1) which is highly expressed in many tumors22. TRAP1 decreases SDH activity and succinate accumulates as a result.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [22] Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [16] Peruzzotti-Jametti, L. et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell 22, 355–368.e13 (2018). source
- Not checked yetcites [17] Bhuniya, D. et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg. Med. Chem. Lett. 21, 3596–3602 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SUCNR1 is highly expressed in mouse kidney, liver, spleen, small intestine3, and on dendritic cells (DCs) 4 and ligand binding induces Gi and Gq signalling cascades3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Extracellular succinate addition also acts in synergy with TLR ligands to increase TNFα and IL-1β expression4 and increases the capacity of DCs to act as antigen presenting cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Specifically, succinate is elevated in plasma after acute exercise and in marathon runners175.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [175] Sivanand, S. et al. Nuclear acetyl-CoA production by ACLY promotes homologous recombination. Mol. Cell 67, 252–265.e56 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“succinate has been shown to act through several pathways to exert its inflammatory effects: through direct generation of mitochondrial ROS (mtROS), by activation of hypoxia-inducible factor-1alpha (HIF-1α; discussed below), and by through ligation of the G-protein coupled receptor succinate receptor 1 (SUCNR1).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a mouse model of multiple sclerosis (MS) transplantation of neural stem cells (NSCs) reduced succinate levels in the cerebrospinal fluid and thereby decreased infiltration of damaging macrophages and microglial cells10.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“He and colleagues made an important discovery when they found that the Krebs cycle-derived metabolites, succinate and α-KG, acted as ligands for the orphan G-protein coupled receptors GPR91 (now known as SUCNR1) and GPR99 (now known as OXRG1), respectively3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This degradation is prevented in conditions of limited oxygen, allowing for HIF-1α translocation to the nucleus, dimerization with HIF-1β and binding of target genes13.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrated that succinate acted as an important hypertensive agent, modulating the renin-angiotensin system via SUCNR1 signalling, independent of its role in bioenergetics3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ROS also impair the activity of Factor Inhibiting HIF (FIH), another member of the α-KGDD family25, which hydroxylates an asparagine residue in the carboxy terminal of HIF-1α resulting in a decrease in transcriptional activity.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent data indicate that succinate is a pro-inflammatory metabolite that accumulates in LPS/IFN-γ-treated macrophages1,2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, ligation of SUCNR1 on the surface of NSCs upregulates the expression of the dicarboxylate co-transporter Slc13a3/5, which correlates with increased uptake by the NSCs thereby scavenging succinate away from pro-inflammatory immune cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“ROS-can stabilize HIF-1α by inducing non-enzymatic decarboxylation of α-KG24 and by oxidizing iron (Fe2+) to Fe3+, two required PHD co-factors25.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [24] Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633–643 (2013). source
- Not checked yetcites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In the absence of SUCNR1 a reduction in absolute numbers of macrophages, but not inflammatory signalling, was observed and this resulted in an improvement in adipose tissue inflammation and improved glucose tolerance in mice following high-fat diet feeding.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The PHDs generate succinate from α-KG, and importantly succinate (acting via product inhibition) will inhibit the PHDs and stabilize HIF-1α21.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [21] Semenza, G. L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24, 97–106 (2009).
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Following LPS treatment both intracellular succinate levels and the cell surface expression of SUCNR1 are increased.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This modification is caused by the accumulation of succinyl-CoA, which can result from SDH inhibition and succinate accumulation38.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that complex I of the ETC is an important site of ROS production in macrophages and such ROS production may depend on RET.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data demonstrate that succinate can have profound impacts on cellular function acting both intracellularly via ROS and HIF-1α, succinylation and histone and DNA modification and extracellularly via SUCNR1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Training with β-glucan was shown to be protective against Staphylococcus aureus infection and this effect was abrogated in HIF-1α-deficient mice.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrate that SIRT5 desuccinylates and activates PKM2 and this limits IL-1β production.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [46] Zhang, Z. et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58–63 (2011). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“DI was first employed as an experimental tool and was shown to potently induce Nrf2 and several Nrf2 target genes in control and LPS-activated BMDMs59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lampropoulou and colleagues (2016) suggested that mechanistically the ability of itaconate to modulate inflammation arose from its ability to competitively inhibit SDH and succinate oxidation50.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
- Not checked yetcites [30] Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S. & Schumacker, P. T. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 28, 718–731 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Since 2016, several key studies have uncovered a role for itaconate as a crucial anti-inflammatory metabolite that negatively regulates the inflammatory response and cytokine production50,59–61, as shown in Figure 3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
- Not checked yetcites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, Irg1-deficient BMDMs, whereby genetic deletion of Irg1 completely abolished itaconate synthesis, exhibited a significant increase in the production of IL-12, IL-6, NO, and under conditions that activate the NLRP3 inflammasome, increased IL-1β and IL-1850.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“LPS-induced HIF-1α not only promotes glycolysis but is also directly pro-inflammatory.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The sustained induction of IL-1β in response to LPS was shown to require HIF-1α and to occur under normoxia.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“SirT5, which was previously thought to function primarily as a deacetylase has been shown to have potent desuccinylase activity 44.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [44] Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Limiting succinate oxidation with the pro-drug dimethylmalonate (DMM), which releases malonate that inhibits SDH function, profoundly represses LPS-induced HIF-1α, IL-1β and ROS and boosts IL-10 and IL-1RA.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Western blot analysis of whole cell lysates revealed that this modification is evolutionarily conserved and that substrates are numerous39 and include proteins involved in cellular metabolism38.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
- Not checked yetcites [39] Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem. J. 417, 1–13 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It is also important to note that itaconate is an α,β-unsaturated carbonyl compound, making it a potential Michael acceptor that could undergo nucleophilic attack by the thiolate ion of protein cysteine residues, as such the methyl esterification of the proximal carboxyl group conjugated to the alkene would be predicted to increase the electrophilicity of itaconate63.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [63] Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl. Acad. Sci. USA. 110, 7820–7825 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, in addition to potentiating cytokine production in response to LPS, training with β-glucan induced epigenetic upregulation of genes involved in glycolysis such as HIF-1α, Hexokinase (HK) and pyruvate kinase and increased succinate levels37.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The loss of HIF-1α in macrophages decreased TNF-α, IL-1β and IL-1α production, but did not affect production of the anti-inflammatory cytokines IL-4 or IL-10 29.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [29] Mu, X. et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget 8, 13174–13185 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“inhibition of IκBξ by DI was shown to be mediated by activation of the transcription factor ATF3 and occur at the level of Nfkbiz translation, as assessed by eIF2α phosphorylation, in a Nrf2-independent manner60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Supplementation of ROS in Irg1-deficient BMDMs increased A20 expression and abolished the break of endotoxin tolerance67.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“DI is reported to selectively inhibit LPS-induced IL-6 while TNF-α levels remain unaffected”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“4-OI was also shown to be protective in an LPS lethality model in vivo, prolonging survival, improving body temperature regulation and decreasing pro-inflammatory cytokine production59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Intriguingly, endogenous fumarate was also found to succinate GAPDH in both mouse and human macrophages, suggesting that elevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation, however, the precise role of fumarate accumulation remains an open question to be explored.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The authors proposed that fumarate accumulation acted to inhibit the KDM5 family of histone demethylases, which subsequently increased the levels of H3K4me3, a marker of active gene transcription, at the promoters of both Tnf and Il6, thus providing the first link between Krebs cycle rewiring and epigenetic regulation in an inflammatory context97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Later, it was also shown that fumarate binds glutathione (forming succinic-glutathione (succinicGSH)), and thereby depletes this antioxidant molecule leading to unscheduled oxidative stress83,84.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [83] Shi, H. Z., Wang, D., Sun, X. N. & Sheng, L. MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1. Eur. Rev. Med. Pharmacol. Sci. 22, 3837–3846 (2018).
- Not checked yetcites [84] Pan, J. et al. Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma. Oncol. Rep. 32, 1957–1966 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This was associated with a decrease in the microRNA miR-378, which targets Irg1 as well as poorer overall survival and clinicopathological parameters.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, in 2002 it was shown that mutations of FH are the cause of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a cancer predisposition syndrome characterised by benign tumours of the smooth muscle of skin and uterus, and a very aggressive form of renal cancer78.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [78] Cheon, Y. P., Xu, X., Bagchi, M. K. & Bagchi, I. C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623–5630 (2003). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This suggestion arose from the observation that the cell-permeable fumaric esters, DMF and MMF, modify and irreversibly inhibit GAPDH enzymatic activity and aerobic glycolysis in peripheral blood mononuclear cells (PBMCs) from mice and MS patients treated with DMF99.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, DMF blocked the association of PKCθ with the costimulatory receptor CD28 and T cell activation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“As Asl cleaves argininosuccinate into arginine and fumarate, the authors proposed that this metabolic pathway accounted for the elevated fumarate levels observed in macrophages1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Blewett and colleagues (2016) demonstrated that dimethyl fumarate (DMF), a potent electrophile which is currently used to treat psoriasis and relapse-remitting MS, but not MMF inhibited the activation of human and mouse T cells 49.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“More recently, Kornberg and colleagues (2018) suggested that a potential consequence of elevated fumarate levels is to negatively regulate glycolysis via succination of the active site cysteine residue (C152) in GAPDH99,100.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
- Not checked yetcites [100] Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524–537 (2011). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The effect of itaconate on ROS production is consistent with a previous study in zebrafish macrophages, which demonstrated that IRG1 was essential for OXPHOS-driven mtROS production and bactericidal killing172.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [172] Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell. Metab. 20, 306–319 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Overexpression of miR-378 suppressed glioma tumour growth both in vitro and in vivo, the epithelial-mesenchymal transition (EMT) and metastasis75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent data demonstrated that fumarate acts as a powerful inhibitor of the TET family of DNA demethylases and of a series of histone demethylases91,92.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). source
- Not checked yetcites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Inhibition of GOT1 by aminooxyacetic acid (AOAA), which decreases D-2-HG levels, promoted expression Foxp3 and the differentiation of TH17 cells to iTregs143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The cause of these so-called 2-hydroxyglutaric acidurias (2HGAs) was attributed to germline mutations in L-2-HG dehydrogenase (L2HGDH) and D-2-HG dehydrogenase (D2HGDH), the mitochondrial enzymes responsible for the conversion of 2-HG to α-KG and thus its breakdown107-109.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [107] Bardella, C. et al. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J. Pathol. 225, 4–11 (2011). source
- Not checked yetcites [108] Laukka, T. et al. Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J. Biol. Chem. 291, 4256–4265 (2016). source
- Not checked yetcites [109] Salminen, A., Kauppinen, A. & Kaarniranta, K. 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell. Mol. Life Sci. 72, 3897–3914 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, these lines of evidence provide a potential model for how fumarate accumulation promotes genomic alterations that could give rise to cancer formation in HLRCC patients, cooperating with the other above-described oncogenic signals it elicits.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Like TH17 cells, CD8+ T cells are highly dependent on the activation of HIF-1α and glycolysis, which is responsible for mediating trafficking into hypoxic tumour environments and inflamed tissue147,148.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [147] Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012). source
- Not checked yetcites [148] Wang, P. et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091–3100 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Here, via its reverse activity, it generates fumarate that inhibits histone lysine demethylase KDM2B, which in turn facilitates the binding of proteins involved in DNA repair177.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the case of D2HGA, about 50% of patients present with D2HGDH mutations, while the remaining half possess mutations in the Krebs cycle enzyme isocitrate dehydrogenase 2 (IDH2), which converts isocitrate to α-KG110.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [110] Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 8, 143–153 (2005). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“T-helper 17 (TH17) cells, derived from naïve CD4+ T cells, are one such subset that rely heavily on a switch from OXPHOS to glycolysis, a process that requires the activation of HIF-1α and induction of RORγt143,146.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
- Not checked yetcites [146] Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17, 510–522 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Consistent with an important role of senescence bypass for the development of tumorigenesis, recent data in HLRCC patients showed that CDKN2A (also known as P16), a key player in senescence, is hypermethylated and suppressed in tumours85.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [85] Frezza, C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus 7, 20160100 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The elevated levels of D-2-HG was associated with increased DNA methylation levels at the Foxp3 locus, the master transcription factor driving iTreg differentiation, resulting in its repression143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, TH17 cell differentiation could be initiated by exogenous addition of D-2-HG to naïve CD4+ T cells or by genetic silencing of TET1 and TET2, established targets of 2-HG143-145.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
- Not checked yetcites [144] Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463 (2011). source
- Not checked yetcites [145] Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 19, 17–30 (2011). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Upon DNA damage, FH localises in the nucleus, where it is phosphorylated by the catalytic subunit of DNA-PK (DNA-PKcs)177.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In support of this unexpected function of fumarate, it was recently shown that the aberrant accumulation of this metabolite in HLRCC correlates with increased endogenous damage, lower DNA repair efficiency and increased sensitivity to poly-ADP ribose polymerase (PARP) inhibitors178.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [178] Kohlhauer, M. et al. Metabolomic profiling in acute ST-segment-elevation myocardial infarction identifies succinate as an early marker of human ischemia-reperfusion injury. J. Am. Heart Assoc. 7, e007546 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although the IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM), it can also inhibit FIH and PHD2, with IC50 values of 1.5 and 7.3 mM, respectively121.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, HIF-1α stabilisation induced LDHA expression and activity, which promiscuously converted glutamine-derived α-KG to L-2-HG149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG produced by mIDH1/2 has been shown to drive a CpG island methylator phenotype (G-CIMP) in both glioma and ICC tumours to promote tumorigenesis, and has also been found to occupy the active site of histone demethylases thereby increasing histone methylation in primary gliomas121,123-125.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
- Not checked yetcites [123] Rzem, R. et al. A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc. Natl. Acad. Sci. USA 101, 16849–16854 (2004). source
- Not checked yetcites [124] Struys, E. A. et al. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 (2005). source
- Not checked yetcites [125] Topçu, M. et al. l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803–2811 (2004). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrate that this is independent of IDH1 and 2 and primarily mediated by LDHA and malate dehydrogenase (MDH) via “promiscuous” reduction of αKG and this is enhanced by acidic pH52.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This metabolic rewiring resulted in a decrease in a common dipeptide found in the brain N-acetyl-aspartyl-glutamate (NAAG), and NAAG levels were found to be significantly lower in IDH-mutant human glioma tissue134.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [134] Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18, 553–567 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, these findings directly link mIDH-derived D-2-HG accumulation to DNA damage, genetic instability and carcinogenesis.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Indeed, D-2-HG accumulation in IDH-mutant glioma has been found to inhibit PHD hydroxylase and stabilise HIF-1α126 and HIF-1αstabilisation has been shown to occur in IDH1-mutant brain tissue127.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Genomic studies have established that somatic mutations in IDH1 and IDH2 are perhaps the first genetic events to occur during tumorigenesis in human glioma and AML, and appear to initiate pathogenesis by a common mechanism103,115-117.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
- Not checked yetcites [115] Yogev, O. et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol. 8, e1000328 (2010). source
- Not checked yetcites [116] Jiang, Y. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158–1168 (2015). source
- Not checked yetcites [117] Sulkowski, P. L. et al. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nat. Genet. 50, 1086–1092 (2018). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Under acidic conditions αKG is protonated and this promotes binding to LDHA and L-2HG production.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, IDH-mutant cells display reduced DNA repair kinetics, accumulate DNA double stranded breaks (DSBs) and are sensitized to alkylating agents131,174.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [131] MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013). source
- Not checked yetcites [174] Mi, W. et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat. Commun. 8, 1088 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the concentrations at which it accumulates under pathogenic conditions suggests HIF-1α stabilisation and impaired collagen biogenesis may contribute to tumorigenicity126-130.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
- Not checked yetcites [127] Nota, B. et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 92, 627–631 (2013). source
- Not checked yetcites [128] Dang, L. & Su, S. M. Isocitrate dehydrogenase mutation and R-2-hydroxyglutarate: from basic discovery to therapeutics development. Annu. Rev. Biochem. 86, 305–331 (2017). source
- Not checked yetcites [129] Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009). source
- Not checked yetcites [130] Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This increase occurred under normoxic conditions and was dependent on HIF-1α stabilisation149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Functionally, L-2HG is both sufficient to try histone methylation, in particular histone 3 lysine 9 (H3K9me3), and can also promote HIF-1α stabilization in normoxia and therefore may assist with hypoxic adaptation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Remarkably, almost all IDH1/2 mutations occur in a few unique locations in the active site of the enzymes, which results in the acquirement of a neomorphic enzymatic activity converting α-KG to the oncometabolite D-2-HG118-120.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [118] Johnson, T. I., Costa, A. S. H., Ferguson, A. N. & Frezza, C. Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation. Cell Death Dis. 9, 913 (2018). source
- Not checked yetcites [119] Ye, D., Guan, K. L. & Xiong, Y. Metabolism, activity, and targeting of d- and l-2-Hydroxyglutarates. Trends Cancer 4, 151–165 (2018). source
- Not checked yetcites [120] Chalmers, R. A. et al. d-2-hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3, 11–15 (1980). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrate that ACLY is required to enhance histone acetylation levels and induce the expression of cell cycle regulating genes in response to IL-2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Citrate, a component of the TCA cycle has been shown to act as a source of acetyl-CoA to drive histone acetylation and this process can have profound impacts on both tumor and immune cell function.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [53] Gibson, G. E. et al. α-ketoglutarate dehydrogenase complex–dependent succinylation of proteins in neurons and neuronal cell lines. J. Neurochem. 134, 86–96 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG has also been found to bind the DNA methyltransferase DNMT1, which subsequently represses receptor-interacting protein kinase 3 (RIP3).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
- Not checked yetcites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically LDHA-deficient T cells showed decreased acetyl-CoA levels and decreased histone H3 acetylation at the lysine 9 residue (H3K9Ac), a histone mark associated with active transcription, on the Ifng promoter.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One of the earliest studies to identify a role for ACL in histone acetylation demonstrated a requirement for this gene in response to growth factor stimulation and during differentiation, for example the differentiation of murine 3T3- L1 pre-adipocytes into adipocytes.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Finally, D-2HG also impairs necroptosis and the small GTPase Cdc42, leading to suppression of mixed lineage kinase 3 (MLK3)-mediated apoptosis140,141.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
- Not checked yetcites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, artificial acetyl-CoA reduction, through inhibition of ACLY, decreased IFN-γ expression and acetate supplementation, which augmented acetyl-CoA production, corrected H3K9Ac marks and IFN-γ expression in LDHA-deficient T cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It has been demonstrated in mammalian cells that histone acetylation is dependent on ACL, the enzyme that converts citrate into acetyl-CoA, a required co-factor for acetylation,54 with ACL silencing decreasing the degree of histone acetylation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ACLY deficiency results in impaired BRCA1 recruitment to sites of DSBs and suppression of homologous recombination.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ACLY is phosphorylated downstream of AKT activation, following DNA damage and this facilitates histone acetylation at double strand break (DSB) sites, enabling breast cancer early onset 1 (BRCA1) recruitment and DNA repair by homologous recombination.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The production of succinate is also enhanced during inflammation13, acting as a signal from mitochondria to the cytosol to activate pro-inflammatory gene expression while also generating ROS as a further pro-inflammatory redox signal28.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
- Not checked yetcites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mice with an T cell-specific LDHA deficiency produced less IFN-γ and were protected from immunopathology.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“D-2-HG has also been found to be a competitive inhibitor of SDH, a key metabolic enzyme and tumour suppressor as previously discussed, resulting in the accumulation of succinate, impaired mitochondrial oxygen consumption and increased protein succinylation139.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [139] Suzuki, H. et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat. Genet. 47, 458–468 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“D-2-HG activates NF-κB in bone marrow stromal cells in an IκB kinase-independent fashion, thus generating a stromal niche for IDH mutant AML development138.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [138] Finlay, D. K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441–2453 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Inhibitors of α-KGDDs are often non-specific, either hitting multiple isoforms or a-KGDD family members, such as dimethyloxaloylglycine (DMOG) acting on TETs but also PHDs [7].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [7] Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41.e7 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a drug Enasidenib has been developed for AML, which binds to the mutated, but not the wild-type, form of IDH2 only to prevent D-2-HG production163.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [163] Chen, J. Y. et al. The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells. Sci. Rep. 6, 1 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One critical point to consider is the limited human and in vivo data existing to date.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Studies in human immune cells are also currently very limited.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“succinate, which promotes a potentially tumour-fighting, pro-inflammatory state also drives HIF-1α activation in tumours which is associated with cancer progression.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
In the paper
“4-OI is an itaconate mimic that was protective in a mouse model of sepsis, decreasing cytokine production and increasing survival59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Alternatively, the nervous system coordinates whole‐body metabolism not only by the production of neurohormones that act locally, but also by direct innervation of the target tissues 2, 3, 4, 5.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Introduction
“As such, the reaction catalysed by OGDH is referred to as substrate level phosphorylation and constitutes the fifth step in the Krebs cycle.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Introduction
“In the fourth step, OGDH catalyses the oxidative decarboxylation of α-KG to form succinyl-CoA, NADH and CO2. Succinyl-CoA synthetase then catalyses the hydrolysis of succinyl-CoA, coupled to the condensation of GDP and inorganic phosphate (Pi), or ADP and Pi, to form succinate and either GTP or ATP.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
“Furthermore, Weiss and colleagues (2018) demonstrated that ROS production in response to itaconate regulates Nrf2, suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > References
“75. Shi H Wang D Sun X S L MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1 Eur Rev Med Pharmacol Sci 2018 6 22 12 3837 3846 10.26355/eurrev_201806_15268 2018 29949160”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
Citations
Cites
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Self-citationAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Cited by
Sorted by citations
Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272
The assembly, regulation and function of the mitochondrial respiratory chain
Vercellino, I., & Sazanov, L. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00415-0 · Cited by 1,015
Therapeutic targeting of the hypoxic tumour microenvironment
Singleton, D. C., Macann, A., & Wilson, W. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00539-4 · Cited by 507
Reactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez‐Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 490
Cancer cell metabolism and antitumour immunity
Martino, M. D., Rathmell, J. C., Galluzzi, L., & Vanpouille‐Box, C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01026-4 · Cited by 385
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages
Runtsch, M. C., Angiari, S., Hooftman, A., Wadhwa, R., Zhang, Y., Zheng, Y., Spina, J. S., Ruzek, M. C., Argiriadi, M. A., McGettrick, A. F., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.002 · Cited by 343
Self-citationCellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334
Metabolic orchestration of the wound healing response
Eming, S. A., Murray, P. J., & Pearce, E. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.017 · Cited by 326
Crosstalk between glucose metabolism, lactate production and immune response modulation
Ye, L., Jiang, Y., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.11.001 · Cited by 326
Lonnemann, N., Hosseini, S., Marchetti, C., Skouras, D. B., Stefanoni, D., D’Alessandro, A., Dinarello, C. A., & Korte, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009680117 · Cited by 298
Oncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function
Notarangelo, G., Spinelli, J. B., Perez, E. M., Baker, G. J., Kurmi, K., Elia, I., Stopka, S. A., Baquer, G., Lin, J., Golby, A. J., et al. (2022) · Science · doi:10.1126/science.abj5104 · Cited by 298
Compartmentalised acyl-CoA metabolism and roles in chromatin regulation
Trefely, S., Lovell, C. D., Snyder, N. W., & Wellen, K. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.005 · Cited by 272
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Choi, I., Son, H., & Baek, J.-H. (2021) · Life · doi:10.3390/life11010069 · Cited by 262
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 253
Targeting memory T cell metabolism to improve immunity
Corrado, M., & Pearce, E. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148546 · Cited by 250
The Immunomodulatory Potential of the Metabolite Itaconate
Hooftman, A., & O'Neill, L. A. J. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.05.007 · Cited by 236
Self-citationItaconate inhibits TET DNA dioxygenases to dampen inflammatory responses
Chen, L., Morcelle, C., Cheng, Z., Chen, X., Xu, Y., Gao, Y., Song, J., Li, Z., Smith, M. D., Shi, M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00853-8 · Cited by 234
D-mannose suppresses macrophage IL-1β production
Torretta, S., Scagliola, A., Ricci, L., Mainini, F., Marco, S. D., Cuccovillo, I., Kajaste‐Rudnitski, A., Sumpton, D. P., Ryan, K. M., & Cardaci, S. (2020) · Nature Communications · doi:10.1038/s41467-020-20164-6 · Cited by 232
Li, T., Tan, Y., Chen, Y., Zheng, X., Wang, W., Liao, K. L., Mo, H., Lin, J., Yang, W., Piao, H., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-326928 · Cited by 226
Yi, Z., Deng, M., Scott, M. J., Fu, G., Loughran, P., Lei, Z., Li, S., Sun, P., Yang, C., Li, W., et al. (2020) · Hepatology · doi:10.1002/hep.31147 · Cited by 218
Banerjee, A., Herring, C. A., Chen, B., Kim, H., Simmons, A. J., Southard-Smith, A. N., Allaman, M. M., White, J. R., Macedonia, M. C., McKinley, E. T., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.029 · Cited by 214
Cytokine-like Roles for Metabolites in Immunity
Zasłona, Z., & O'Neill, L. A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.002 · Cited by 202
Self-citationMitochondrial Stress Response and Cancer
O’Malley, J., Kumar, R., Inigo, J. R., Yadava, N., & Chandra, D. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.009 · Cited by 197
Ins and outs of the TCA cycle: the central role of anaplerosis
Inigo, M., Deja, S., & Burgess, S. C. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-025558 · Cited by 189
Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1/GPR91-mediated Gq signaling
Trauelsen, M., Hiron, T. K., Lin, D., Petersen, J. E., Breton, B., Husted, A. S., Hjorth, S. A., Inoue, A., Frimurer, T. M., Bouvier, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109246 · Cited by 189
Lactate Rewires Lipid Metabolism and Sustains a Metabolic–Epigenetic Axis in Prostate Cancer
Ippolito, L., Comito, G., Parri, M., Iozzo, M., Duatti, A., Virgilio, F., Lorito, N., Bacci, M., Pardella, E., Sandrini, G., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-0914 · Cited by 188
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation
Shang, M., Yang, H., Yang, R., Chen, T., Fu, Y., Li, Y., Fang, X.-L., Zhang, K., Jianju, Z., Li, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22173-5 · Cited by 186
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178
Divakaruni, A. S., & Jastroch, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00619-4 · Cited by 162
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Li, R., Li, X., Zhao, J., Meng, F., Yao, C., Bao, E.-S., Sun, N., Chen, X., Cheng, W., Hua, H. M., et al. (2021) · Theranostics · doi:10.7150/thno.63751 · Cited by 159
A common framework of monocyte-derived macrophage activation
Sanin, D. E., Ge, Y., Marinković, E., Kabat, A. M., Castoldi, Â., Caputa, G., Grzes, K. M., Curtis, J. D., Thompson, E. A., Willenborg, S., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl7482 · Cited by 161
Xiong, Y., Knoedler, S. A., Alfertshofer, M. G., Kim, B., Jiang, D., Liu, G., Rinkevich, Y., & Mi, B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07583-3 · Cited by 157
Mitochondrial long non-coding RNA GAS5 tunes TCA metabolism in response to nutrient stress
Sang, L., Ju, H., Yang, Z., Ge, Q., Zhang, Z., Liu, F., Yang, L.-J., Gong, H., Shi, C., Qu, L., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00325-z · Cited by 155
Chi, Z., Chen, S., Xu, T., Zhen, W., Yu, W., Jiang, D., Guo, X., Wang, Z., Zhang, K., Li, M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.015 · Cited by 156
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 151
Huang, H., Li, G., He, Y., Chen, J., Yan, J., Zhang, Q., Li, L., & Cai, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404441 · Cited by 155
Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages
Harber, K. J., de Goede, K. E., Verberk, S. G. S., Meinster, E., de Vries, H. E., van Weeghel, M., de Winther, M. P. J., & den Bossche, J. V. (2020) · Metabolites · doi:10.3390/metabo10090372 · Cited by 144
Deng, H., Wu, L., Liu, M., Zhu, L., Chen, Y., Zhou, H., Shi, X., Wei, J., Li, Z., Hu, X., et al. (2020) · Shock · doi:10.1097/shk.0000000000001549 · Cited by 143
Quantitative Sub-Cellular Acyl-Coa Analysis Reveals Distinct Nuclear Regulation
Trefely, S., Huber, K., Liu, J., Noji, M., Stransky, S., Singh, J. P., Doan, M. T., Lovell, C. D., von Krusenstiern, E. V., Jiang, H., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.006 · Cited by 139
A break in mitochondrial endosymbiosis as a basis for inflammatory diseases
Murphy, M. P., & O’Neill, L. A. J. (2024) · Nature · doi:10.1038/s41586-023-06866-z · Cited by 138
Self-citationControl of endothelial quiescence by FOXO-regulated metabolites
Andrade, J., Shi, C., Costa, A. S. H., Choi, J., Kim, J., Doddaballapur, A., Sugino, T., Ong, Y. T., Castro, M., Zimmermann, B., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00637-6 · Cited by 133
Self-citationLee, C. Q. E., Kerouanton, B., Chothani, S. P., Zhang, S., Chen, Y., Mantri, C. K., Hock, D. H., Lim, R., Nadkarni, R., Huynh, V. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22397-5 · Cited by 132
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130
Dysregulation of metabolic pathways in pulmonary fibrosis
Rajesh, R., Atallah, R., & Bärnthaler, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108436 · Cited by 132
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 128
Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy
Zou, W., & Green, D. R. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.003 · Cited by 122
Ježek, P., Jabůrek, M., Holendová, B., Engstová, H., & Dlasková, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0173 · Cited by 117
Origins and diversity of macrophages in health and disease
Sreejit, G., Fleetwood, A. J., Murphy, A. J., & Nagareddy, P. R. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1222 · Cited by 112
Ryan, D. G., Knatko, E. V., Casey, A. M., Hukelmann, J. L., Naidu, S. D., Brenes, A. J., Ekkunagul, T., Baker, C. P., Higgins, M., Tronci, L., et al. (2021) · iScience · doi:10.1016/j.isci.2022.103827 · Cited by 112
Self-citationJiang, Q., Qiu, Y., Kurland, I. J., Drlica, K., Subbian, S., Tyagi, S., & Shi, L. (2022) · mBio · doi:10.1128/mbio.01274-22 · Cited by 98
Insulin as an immunomodulatory hormone
van Niekerk, G., Christowitz, C., Conradie, D., & Engelbrecht, A. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.006 · Cited by 95
Gu, X., Wei, H., Suo, C., Shen, S., Zhu, C., Chen, L., Yan, K., Li, Z., Bian, Z., Zhang, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43988-4 · Cited by 95
Zinc and Cadmium in the Aetiology and Pathogenesis of Osteoarthritis and Rheumatoid Arthritis
Frangos, T., & Maret, W. (2020) · Nutrients · doi:10.3390/nu13010053 · Cited by 94
Chen, X., Sunkel, B. D., Wang, M., Kang, S., Wang, T., Gnanaprakasam, J. R., Liu, L., Cassel, T., Scott, D. A., Muñoz-Cabello, A. M., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm8161 · Cited by 94
Zhao, Q., Wang, Q., Yao, Q., Yang, Z., Li, W., Cheng, X., Wen, Y., Chen, R., Xu, J., Wang, X., et al. (2025) · Cell Research · doi:10.1038/s41422-024-01060-w · Cited by 93
Succinate Receptor 1: An Emerging Regulator of Myeloid Cell Function in Inflammation
Krzak, G., Willis, C. M., Smith, J. A., Pluchino, S., & Peruzzotti‐Jametti, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.11.004 · Cited by 91
Multifaceted mitochondria in innate immunity
Marques, E., Kramer, R., & Ryan, D. G. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00008-3 · Cited by 91
Self-citationKrebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
Gasmi, A., Peana, M., Arshad, M., Butnariu, M., Menzel, A., & Bjørklund, G. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02974-9 · Cited by 88
Bae, S., Park, P. S. U., Lee, Y., Mun, S. H., Γιαννοπούλου, Ε., Fujii, T., Lee, K. P., Violante, S. N., Cross, J. R., & Park‐Min, K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109264 · Cited by 81
Evolution of glutamatergic signaling and synapses
Moroz, L. L., Nikitin, M. A., Poličar, P. G., Kohn, A. B., & Romanova, D. Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108740 · Cited by 81
Effects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds
Sun, J., Xu, X., & Jin, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880286 · Cited by 81
The metabolic spectrum of memory T cells
O’Sullivan, D. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12274 · Cited by 80
Itaconate: A Potent Macrophage Immunomodulator
Li, Z., Zheng, W., Kong, W., & Zeng, T. (2023) · Inflammation · doi:10.1007/s10753-023-01819-0 · Cited by 79
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 75
Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses
Lesbats, J., Brillac, A., Reisz, J. A., Mukherjee, P., Lhuissier, C., Fernández-Monreal, M., Dupuy, J.-W., Sequeira, A., Tioli, G., De La Calle Arregui, C., et al. (2025) · Nature · doi:10.1038/s41586-025-08629-4 · Cited by 74
Chausse, B., Lewen, A., Poschet, G., & Kann, O. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.052 · Cited by 74
Liu, X., Zhu, C., Zha, H., Tang, J., Rong, F., Chen, X., Fan, S., Xu, C., Du, J., Zhu, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103285 · Cited by 74
The Immune Consequences of Lactate in the Tumor Microenvironment
Harmon, C., O’Farrelly, C., & Robinson, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_7 · Cited by 73
Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review
Silva, C. L., Perestrelo, R., Silva, P., Tomás, H., & Câmara, J. S. (2019) · Metabolites · doi:10.3390/metabo9050102 · Cited by 72
Autophagy in metabolism and quality control: opposing, complementary or interlinked functions?
Deretic, V., & Kroemer, G. (2022) · Autophagy · doi:10.1080/15548627.2021.1933742 · Cited by 71
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
Lin, J., Ren, J., Gao, D. S., Dai, Y., & Yu, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.669308 · Cited by 71
Liu, Q., Zhuang, Y., Song, X., Niu, Q., Sun, Q., Li, X., Li, N., Liu, B., Huang, F., & Qiu, Z. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00535-x · Cited by 67
Succinate and inosine coordinate innate immune response to bacterial infection
Jiang, M., Chen, Z., Li, H., Zhang, T., Yang, M., Peng, X., & Peng, B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010796 · Cited by 64
Sun, H., Zheng, G.-L., Wang, Z.-C., Liu, Y., Bao, N., Xiao, P., Lu, Q.-B., & Zhang, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155175 · Cited by 62
A sensitive mass spectrometric assay for mitochondrial CoQ pool redox state in vivo
Burger, N., Logan, A., Prime, T. A., Mottahedin, A., Caldwell, S. T., Krieg, T., Hartley, R. C., James, A. M., & Murphy, M. P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.11.028 · Cited by 60
Self-citationGlutarate regulates T cell metabolism and anti-tumour immunity
Minogue, E., Cunha, P. P., Wadsworth, B. J., Grice, G. L., Sah‐Teli, S. K., Hughes, R. J. F., Bargiela, D., Quaranta, A., Zurita, J., Antrobus, R., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00855-2 · Cited by 60
Mitochondria orchestrate macrophage effector functions in atherosclerosis
Dumont, A., Lee, M., Barouillet, T., Murphy, A. J., & Yvan‐Charvet, L. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100922 · Cited by 60
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
Ježek, P., Holendová, B., & Plecitá‐Hlavatá, L. (2020) · Biomolecules · doi:10.3390/biom10010093 · Cited by 59
Guillon, A., Bréa, D., Cezard, A., Wacquiez, A., Baranek, T., Bourgeais, J., Picou, F., Vasseur, V., Meyer, L., Chevalier, C., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108306 · Cited by 58
Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 59
D’Alessandro, A., Akpan, I. J., Thomas, T., Reisz, J. A., Cendali, F. I., Gamboni, F., Nemkov, T. G., Thangaraju, K., Katneni, U., Tanaka, K. A., et al. (2021) · Cells · doi:10.3390/cells10092293 · Cited by 57
Williams, N. C., Ryan, D. G., Costa, A. S. H., Mills, E. L., Jedrychowski, M. P., Cloonan, S. M., Frezza, C., & O'Neill, L. A. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101501 · Cited by 57
Self-citationCobley, J. N. (2020) · Antioxidants · doi:10.3390/antiox9100933 · Cited by 57
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 57
Li, T., Kong, L., Li, X., Wu, S., Attri, K. S., Li, Y., Gong, W., Zhao, B. L., Li, L., Herring, L. E., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00843-2 · Cited by 56
RetractedAli, R., Quinn, G. M., Umarova, R., Haddad, J. A., Zhang, G. Y., Townsend, E. C., Scheuing, L., Hill, K., Gewirtz, M. A., Rampertaap, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01273-y · Cited by 55
Impaired phosphocreatine metabolism in white adipocytes promotes inflammation
Maqdasy, S., Lecoutre, S., Renzi, G., Frendo‐Cumbo, S., Rizo‐Roca, D., Möritz, T., Juvany, M., Hodek, O., Gao, H., Couchet, M., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00525-9 · Cited by 54
Cancer immunometabolism: advent, challenges, and perspective
Dang, Q., Li, B., Jin, B., Zeng, Y., Lou, X., Wang, T., Wang, Y., Pan, X., Hu, Q., Li, Z., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01981-5 · Cited by 55
Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism
Horn, C. M., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621750 · Cited by 53
Lund, J. T., Breum, A. W., Gil, C., Falk, S., Sass, F., Isidor, M. S., Dmytriyeva, O., Ranea‐Robles, P., Mathiesen, C. V., Basse, A. L., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00780-4 · Cited by 52
Mitochondrial Regulation of Macrophage Response Against Pathogens
Choudhuri, S., Chowdhury, I. H., & Garg, N. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.622602 · Cited by 49
Cancer Etiology: A Metabolic Disease Originating from Life’s Major Evolutionary Transition?
Poljšak, B., Kovač, V., Dahmane, R. G., Levec, T., & Starc, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7831952 · Cited by 48
Fumarate suppresses B-cell activation and function through direct inactivation of LYN
Cheng, J., Liu, Y., Yan, J., Zhao, L., Zhou, Y., Shen, X.-Y., Chen, Y., Chen, Y., Meng, X., Zhang, X., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01052-0 · Cited by 49
Xu, J., Yang, Y., Li, X., Ding, S., Zheng, L., Xiong, C., & Yang, Y. (2023) · iMeta · doi:10.1002/imt2.124 · Cited by 47
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 47
Metabolic Plasticity in Ovarian Cancer Stem Cells
Ghoneum, A., Gonzalez, D., Abdulfattah, A. Y., & Said, N. A. (2020) · Cancers · doi:10.3390/cancers12051267 · Cited by 47
Inflammation driven metabolic regulation and adaptation in macrophages
Gupta, S., & Sarangi, P. P. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109216 · Cited by 46
Bundgaard, A., Ruhr, I. M., Fago, A., & Galli, G. L. J. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.01.002 · Cited by 46
Salminen, T. S., & Vale, P. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00521 · Cited by 46
Trejo‐Solís, C., Silva‐Adaya, D., Serrano-García, N., Magaña-Maldonado, R., Jiménez‐Farfán, D., Ferreira-Guerrero, E., Cruz-Salgado, A., & Castillo‐Rodríguez, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417633 · Cited by 44
Metadata
- Authors
- Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L.
- Affiliations
- Trinity College Dublin (IE)
- University of Cambridge (GB)
- Harvard University (US)
- ORCID
- Venue
- Nature Metabolism
- Published
- 2018-12-30
- Volume
- 1
- Issue
- 1
- Pages
- 16-33
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC6485344
- OpenAlex
- W2907926991
- Semantic Scholar
- b15b8b89360b980cc180d451684d173275b9488c
- Cited by
- 398
- References
- 204
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 70 · 2023: 41 · 2022: 66 · 2021: 66 · 2020: 61 · 2019: 20
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (110158/Z/15/Z, 205455, 110159/Z/ 15/Z, 109443/Z/15/Z)
- Medical Research Council (MC_UU_00015/3, MC_UU_12022/6)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Krebs cycle metabolites, metabolic reprogramming, succinic acid, fumarate, itaconate, 2-hydroxyglutarate, acetyl-CoA, immune cell function, cancer, carcinogenesis, tumor immunology, therapeutic target
- MeSH terms
- Citric Acid Cycle, Humans, Immunity, Innate, Macrophages, Neoplasms, Succinate Dehydrogenase, Succinates, Signal Transduction, Succinic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review